129 related articles for article (PubMed ID: 12378408)
1. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.
Radford KJ; Higgins DE; Pasquini S; Cheadle EJ; Carta L; Jackson AM; Lemoine NR; Vassaux G
Gene Ther; 2002 Nov; 9(21):1455-63. PubMed ID: 12378408
[TBL] [Abstract][Full Text] [Related]
2. Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cells.
Radford KJ; Jackson AM; Wang JH; Vassaux G; Lemoine NR
Int J Cancer; 2003 Jul; 105(6):811-9. PubMed ID: 12767067
[TBL] [Abstract][Full Text] [Related]
3. Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo.
Nitcheu-Tefit J; Dai MS; Critchley-Thorne RJ; Ramirez-Jimenez F; Xu M; Conchon S; Ferry N; Stauss HJ; Vassaux G
J Immunol; 2007 Aug; 179(3):1532-41. PubMed ID: 17641019
[TBL] [Abstract][Full Text] [Related]
4. Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.
Dai MS; Vassaux G; Xu M; You RI; Hsieh YF; Ouisse LH; Lo KY; Sytwu HK; Chao TY
Vaccine; 2012 Nov; 30(48):6903-11. PubMed ID: 22982404
[TBL] [Abstract][Full Text] [Related]
5. Recombinant E. coli LLO/OVA induces murine BMDCs maturation via TLR4 and NOD1 receptor and promotes specific cytotoxic T cell immunity.
Xu M; Dai MS
Biomed Environ Sci; 2010 Oct; 23(5):350-6. PubMed ID: 21112482
[TBL] [Abstract][Full Text] [Related]
6. The presentation of class I and class II epitopes of listeriolysin O is regulated by intracellular localization and by intercellular spread of Listeria monocytogenes.
Hiltbold EM; Safley SA; Ziegler HK
J Immunol; 1996 Aug; 157(3):1163-75. PubMed ID: 8757622
[TBL] [Abstract][Full Text] [Related]
7. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
Mandal M; Lee KD
Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
[TBL] [Abstract][Full Text] [Related]
8. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
9. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12.
Higgins DE; Shastri N; Portnoy DA
Mol Microbiol; 1999 Mar; 31(6):1631-41. PubMed ID: 10209738
[TBL] [Abstract][Full Text] [Related]
10. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
11. Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine.
Sun X; Provoda C; Lee KD
J Control Release; 2010 Dec; 148(2):219-25. PubMed ID: 20620181
[TBL] [Abstract][Full Text] [Related]
12. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
Svensson M; Wick MJ
Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
[TBL] [Abstract][Full Text] [Related]
13. Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages.
Catic A; Dietrich G; Gentschev I; Goebel W; Kaufmann SH; Hess J
Microbes Infect; 1999 Feb; 1(2):113-21. PubMed ID: 10594975
[TBL] [Abstract][Full Text] [Related]
14. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Chicken Egg Ovalbumin to Dendritic Cells by Listeriolysin O-Secreting Vegetative
Roeske K; Stachowiak R; Jagielski T; Kamiński M; Bielecki J
J Microbiol Biotechnol; 2018 Jan; 28(1):122-135. PubMed ID: 29361209
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity.
Brown M; Zhang Y; Dermine S; de Wynter EA; Hart C; Kitchener H; Stern PL; Skinner MA; Stacey SN
Gene Ther; 2000 Oct; 7(19):1680-9. PubMed ID: 11083477
[TBL] [Abstract][Full Text] [Related]
19. Sticholysin II shows similar immunostimulatory properties to LLO stimulating dendritic cells and MHC-I restricted T cell responses of heterologous antigen.
Del Valle A; Acosta-Rivero N; Laborde RJ; Cruz-Leal Y; Cabezas S; Luzardo MC; Alvarez C; Labrada M; Rodríguez A; Rodríguez GL; Raymond J; Nogueira CV; Grubaugh D; Fernández LE; Higgins D; Lanio ME
Toxicon; 2021 Sep; 200():38-47. PubMed ID: 34237340
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cytokines in murine BMDCs induced by recombinant E.coli LLO/OVA via TLR4 and NOD1 receptors].
Xu M; Dai MS; Mi C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jan; 25(1):9-12. PubMed ID: 19126379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
